| Michael L Smith Dds Inc | |
|
1271 Robert C Byrd Dr Crab Orchard WV 25827-1446 | |
| (304) 253-4473 | |
| (304) 253-1939 |
| Full Name | Michael L Smith Dds Inc |
|---|---|
| Speciality | Dentist |
| Location | 1271 Robert C Byrd Dr, Crab Orchard, West Virginia |
| Authorized Official Name and Position | Michael Lawson Smith (PRESIDENT DENTIST) |
| Authorized Official Contact | 3042534473 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Michael L Smith Dds Inc Po Box 1446 1271 Robert C Byrd Dr Crab Orchard WV 25827-1446 Ph: (304) 253-4473 | Michael L Smith Dds Inc 1271 Robert C Byrd Dr Crab Orchard WV 25827-1446 Ph: (304) 253-4473 |
| NPI Number | 1144231978 |
|---|---|
| Provider Enumeration Date | 08/10/2006 |
| Last Update Date | 04/22/2015 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144231978 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 3092 (West Virginia) | Primary |
News Archive
According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease.
At the September meeting of the Los Angeles County Personal Assistance Services Council (PASC), officials from the Department of Public Social Services (DPSS) announced that nearly 40,000 Los Angeles County seniors and people living with disabilities who rely on the State's In-Home Supportive Services (IHSS) program for vital care will either lose all or some of their care hours due to State budget cuts.
A monoclonal antibody targeting a protein known as SFPR2 has been shown by researchers at the University of North Carolina to inhibit tumor growth in pre-clinical models of breast cancer and angiosarcoma.
Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.
› Verified 9 days ago